House Hearing Probes FDA’s Cosmetics Role
This article was originally published in The Rose Sheet
Executive Summary
Stakeholders from industry, government and FDA discussed ideas for changing the agency’s oversight of cosmetics at a House subcommittee meeting March 27. The need for a national regulatory system, mandatory recalls, company and ingredient registration and adverse event reporting were debated.